CASI(Delisted)
CASI Pharmaceuticals·NASDAQ
--
--(--)
CASI Filings
Filing Date
Form Description
Form Type
2026-04-07
Form 3 - Initial statement of beneficial ownership of securities
Ownership
2026-04-07 · Ownership
Form 3 - Initial statement of beneficial ownership of securities
2026-04-03
Form 3 - Initial statement of beneficial ownership of securities
Ownership
2026-04-03 · Ownership
Form 3 - Initial statement of beneficial ownership of securities
2026-04-03
Form 3 - Initial statement of beneficial ownership of securities
Ownership
2026-04-03 · Ownership
Form 3 - Initial statement of beneficial ownership of securities
2026-03-27
Form 3 - Initial statement of beneficial ownership of securities
Ownership
2026-03-27 · Ownership
Form 3 - Initial statement of beneficial ownership of securities
2026-03-25
Form 3 - Initial statement of beneficial ownership of securities
Ownership
2026-03-25 · Ownership
Form 3 - Initial statement of beneficial ownership of securities
2026-03-23
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2026-03-23 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2026-03-18
Form 3 - Initial statement of beneficial ownership of securities
Ownership
2026-03-18 · Ownership
Form 3 - Initial statement of beneficial ownership of securities
2026-03-18
Form 3 - Initial statement of beneficial ownership of securities
Ownership
2026-03-18 · Ownership
Form 3 - Initial statement of beneficial ownership of securities
2026-03-03
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-03-03 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-02-26
Form D - Notice of Exempt Offering of Securities
2026-02-26 ·
Form D - Notice of Exempt Offering of Securities
